Simultaneously, an exploration of differentially expressed genes (DEGs) between TP53-mutated and wild-type lung cancer patients in TCGA data unveiled elevated transcription levels of DSG3 in the former (Fig. 1D). This evidence concerns the gene DSG3 and lung cancer.